Home›Stock Screener›Glen Industries›Quarterly Results

Glen Industries Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹18 Cr
QMarch 2025
Quarterly Results

In 2026, Glen Industries (GLEN) reported revenue ₹0 Cr and net profit ₹0 Cr. Also explore GLEN share price data to track price trends across different timeframes.

GLEN Quarterly Results — Revenue, Profit & EPS Highlights

Glen Industries latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit GLEN share price.

  • Revenue of ₹171 Cr in March 2025 (+0.0% vs March 2025, +17.9% vs March 2024)
  • Net Profit of ₹18 Cr in March 2025 (+0.0% vs March 2025, +100.0% vs March 2024)
  • EBITDA of ₹41 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 24.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹10.37 in March 2025 (+0.0% vs March 2025)

Glen Industries Quarterly Results — Revenue, EBITDA, Net Profit & EPS

GLEN quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 0 171 145 120 97 - -
Net Profit (₹ Cr) 0 18 9 2 4 - -
EBITDA (₹ Cr) 0 41 25 17 14 - -
EPS (₹) 0.00 10.37 82.42 0.85 2.09 - -
Operating Margin (%) 0.0% 24.0% 17.0% 14.0% 12.0% - -

GLEN Share Price Trend — 1-Year Movement Across Quarterly Results

Glen Industries 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Compare with GLEN fair value estimate to assess whether the stock is under or overvalued.

Profitability Ratios

Profit Margin 10.5%
EBITDA Margin 24.0%
Operating Margin 24.0%
ROE (Annual) 30.5%

Balance Sheet Highlights

Total Assets ₹214 Cr
Total Equity ₹59 Cr
Current Assets ₹104 Cr
Current Liabilities ₹56 Cr

Cash Flow Analysis

Operating Cash Flow ₹6 Cr
Investing Cash Flow ₹-35 Cr
Financing Cash Flow ₹30 Cr
Net Cash Flow ₹1 Cr

Revenue Trend (₹ Cr)

March 2023 120
March 2024 145
March 2025 171
2026 0

Net Profit Trend (₹ Cr)

March 2023 2
March 2024 9
March 2025 18
2026 0

Operating Margin Trend (%)

March 2023 14.0%
March 2024 17.0%
March 2025 24.0%
2026 0.0%

GLEN vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Glen Industries latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹450,643.09 Cr 1878.2 14,875 3,125 +10.8% - 21.0% 144.5
Divis Laboratories
Sept 2025 		₹178,235.60 Cr 6760.5 2,860 689 +7.1% - 24.1% 260.3
Torrent Pharmaceuti…
Sept 2025 		₹149,048.00 Cr 4405.7 3,219 591 +11.3% - 18.4% 251.2
Cipla
Mar 2026 		₹116,053.85 Cr 1432.1 6,612 543 -14.3% -4.0% 8.2% 208.5
Dr Reddys Laborator…
Mar 2026 		₹108,804.06 Cr 1336.7 7,996 221 -12.5% -11.5% 2.8% 504.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores